ӳ��ý

Publications

Bridging silicon and carbon worlds with digital twins and on-chip systems in drug discovery.

Akbarialiabad H, Seyyedi MS, Paydar S, Habibzadeh A, Haghighi A, Kvedar JC. Bridging silicon and carbon worlds with digital twins and on-chip systems in drug discovery. NPJ systems biology and applications. 2024;10(1):150. doi:10.1038/s41540-024-00476-9

Historical and Archaeogenomic Identification of High-Status Englishmen at Jamestown, Virginia.

Owsley DW, Bruwelheide KS, Harney E, et al. Historical and Archaeogenomic Identification of High-Status Englishmen at Jamestown, Virginia. Antiquity. 2024;98(400):1040-1054. doi:10.15184/aqy.2024.75

Probabilistic medical predictions of large language models.

Gu B, Desai RJ, Lin KJ, Yang J. Probabilistic medical predictions of large language models. NPJ digital medicine. 2024;7(1):367. doi:10.1038/s41746-024-01366-4

Assembling Ancestors: the manipulation of Neolithic and Gallo-Roman skeletal remains from Pommerœul, Belgium.

Veselka B, Reich D, Capuzzo G, et al. Assembling Ancestors: the manipulation of Neolithic and Gallo-Roman skeletal remains from Pommerœul, Belgium. Antiquity. 2024;98(402):1576-1591. doi:10.15184/aqy.2024.158

Steroid-Resistant Nephrotic Syndrome Is Associated With a Unique Genetic Profile in a Highly Admixed Pediatric Population.

Watanabe A, Neves PDM de M, Nunes K, et al. Steroid-Resistant Nephrotic Syndrome Is Associated With a Unique Genetic Profile in a Highly Admixed Pediatric Population. Kidney international reports. 2024;9(12):3501-3516. doi:10.1016/j.ekir.2024.09.005

Potassium/sodium cation carriers robustly up-regulate CD20 antigen by targeting MYC, and synergize with anti-CD20 immunotherapies to eliminate malignant B cells.

Torun A, Zdanowicz A, Miazek-Zapala N, et al. Potassium/sodium cation carriers robustly up-regulate CD20 antigen by targeting MYC, and synergize with anti-CD20 immunotherapies to eliminate malignant B cells. Haematologica. 2024. doi:10.3324/haematol.2024.285826

Count Me In: patient-partnered research to address disparities for rare cancer patients.

Bhakhri P, Phelps K, Zañudo JGT, et al. Count Me In: patient-partnered research to address disparities for rare cancer patients. Therapeutic advances in rare disease. 2024;5:26330040241304440. doi:10.1177/26330040241304440

Understanding rare genetic variants within the terminal pathway of complement system in preeclampsia.

Lokki I, Triebwasser M, Daly E, et al. Understanding rare genetic variants within the terminal pathway of complement system in preeclampsia. Genes and immunity. 2024. doi:10.1038/s41435-024-00310-6

Expression of CK17 and SOX2 in Vulvar Intraepithelial Neoplasia: A Comprehensive Analysis of 150 Vulvar Lesions.

Thuijs NB, Voss FO, Ewing-Graham PC, et al. Expression of CK17 and SOX2 in Vulvar Intraepithelial Neoplasia: A Comprehensive Analysis of 150 Vulvar Lesions. Cancers. 2024;16(23). doi:10.3390/cancers16233966

Expression of CK17 and SOX2 in Vulvar Intraepithelial Neoplasia: A Comprehensive Analysis of 150 Vulvar Lesions.

Thuijs NB, Voss FO, Ewing-Graham PC, et al. Expression of CK17 and SOX2 in Vulvar Intraepithelial Neoplasia: A Comprehensive Analysis of 150 Vulvar Lesions. Cancers. 2024;16(23). doi:10.3390/cancers16233966